Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
imported>Anypodetos |
|||
(46 intermediate revisions by 24 users not shown) | |||
Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
− | | name | + | | name = Lipid modifying agents |
− | | title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | + | | title = [[Hypolipidemic agent|Lipid-modifying agents]] ([[ATC code C10|C10]]) |
− | | | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
+ | | listclass = hlist | ||
− | | group1 = [[GI tract]] | + | | group1 = [[Human gastrointestinal tract|GI tract]] |
− | | | + | | list1 = {{Navbox|child |
− | | | ||
− | | group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]] | + | | group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]] |
− | | | + | | list1 = |
+ | * [[Ezetimibe]] | ||
+ | * [[SCH-48461]] | ||
− | | group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]]) | + | | group2 = [[Bile acid sequestrant]]s/[[Ion-exchange resin|resins]] ([[Low-density lipoprotein|LDL]]) |
− | | list2 | + | | list2 = |
+ | * [[Colesevelam]] | ||
+ | * [[Colestilan]] | ||
+ | * [[Colestipol]] | ||
+ | * [[Colestyramine]] | ||
+ | * [[Colextran]] | ||
− | }} | + | }} |
+ | | group2 = [[Liver]] | ||
+ | | list2 = {{Navbox|child | ||
− | | | + | | group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]]) |
− | | | + | | list1 = |
− | + | * [[Atorvastatin]] | |
+ | * [[Cerivastatin]]<sup>‡</sup> | ||
+ | * [[Fluvastatin]] | ||
+ | * [[Lovastatin]] | ||
+ | * [[Mevastatin]] | ||
+ | * [[Pitavastatin]] | ||
+ | * [[Pravastatin]] | ||
+ | * [[Rosuvastatin]] | ||
+ | * [[Simvastatin]]<sup>#</sup> | ||
− | | | + | | group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]]) |
− | | | + | | list2 = |
+ | * [[Acipimox]] | ||
+ | * [[Aluminium nicotinate]] | ||
+ | * [[Niacin]] | ||
+ | * [[Niceritrol]] | ||
+ | * [[Nicofuranose]] | ||
+ | * [[Nicotinyl alcohol]] | ||
− | | | + | | group3 = [[Microsomal triglyceride transfer protein|MTTP]] inhibitors ([[Very low-density lipoprotein|VLDL]]) |
− | | | + | | list3 = |
+ | * [[Dirlotapide]] | ||
+ | * [[Lomitapide]] | ||
+ | * [[Mitratapide]] | ||
− | + | | group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]]) | |
+ | | list4 = | ||
+ | * [[Bempedoic acid]] | ||
− | + | }} | |
− | |||
− | |||
− | | | + | | group3 = [[Blood vessel]]s |
− | | | + | | list3 = {{Navbox|child |
+ | | evenodd = swap | ||
+ | | group1 = [[Fibrate]]s ([[PPAR agonist|PPAR]]) | ||
+ | | list1 = | ||
+ | * [[Aluminium clofibrate]] | ||
+ | * [[Bezafibrate]] | ||
+ | * [[Choline fenofibrate]] | ||
+ | * [[Ciprofibrate]] | ||
+ | * [[Clinofibrate]] | ||
+ | * [[Clofibrate]]<sup>‡</sup> | ||
+ | * [[Clofibride]] | ||
+ | * [[Etofibrate]] | ||
+ | * [[Fenofibrate]] | ||
+ | * [[Gemfibrozil]] | ||
+ | * [[Pemafibrate]] | ||
+ | * [[Ronifibrate]] | ||
+ | * [[Simfibrate]] | ||
− | | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]]) | + | | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]]) |
− | | | + | | list2 = |
+ | * [[Anacetrapib]]<sup>†</sup> | ||
+ | * [[Dalcetrapib]]<sup>§</sup> | ||
+ | * [[Evacetrapib]]<sup>§</sup> | ||
+ | * [[Obicetrapib]]<sup>†</sup> | ||
+ | * [[Torcetrapib]]<sup>§</sup> | ||
+ | | group3 = [[PCSK9 inhibitor]]s ([[Low-density lipoprotein|LDL]]) | ||
+ | | list3 = | ||
+ | * [[Alirocumab]] | ||
+ | * [[Bococizumab]] | ||
+ | * [[Evolocumab]] | ||
+ | }} | ||
− | + | | group4 = Combinations | |
+ | | list4 = | ||
+ | * [[Amlodipine/atorvastatin]] | ||
+ | * [[Bempedoic acid/ezetimibe]] | ||
+ | * [[Ezetimibe/atorvastatin]] | ||
+ | * [[Ezetimibe/rosuvastatin]] | ||
+ | * [[Ezetimibe/simvastatin]] | ||
+ | * [[Fenofibrate/pravastatin]] | ||
+ | * [[Fenofibrate/simvastatin]] | ||
+ | * [[Laropiprant|Niacin/laropiprant]] | ||
+ | * [[Niacin/lovastatin]] | ||
+ | * [[Niacin/simvastatin]] | ||
+ | | group5 = Other | ||
+ | | list5 = | ||
+ | * [[Alipogene tiparvovec]] | ||
+ | * [[Azacosterol]] | ||
+ | * [[Azalanstat]] | ||
+ | * [[Benfluorex]]<sup>‡</sup> | ||
+ | * [[Darapladib]]<sup>§</sup> | ||
+ | * [[Dextrothyroxine]]<sup>‡</sup> | ||
+ | * [[Inclisiran]] | ||
+ | * [[Lapaquistat]]<sup>§</sup> | ||
+ | * [[Magnesium pyridoxal 5-phosphate glutamate]] | ||
+ | * [[Meglutol]] | ||
+ | * [[Mipomersen]] | ||
+ | * [[Omega-3-triglycerides]] | ||
+ | * [[Policosanol]] | ||
+ | * [[Probucol]] | ||
+ | * [[Tiadenol]] | ||
+ | * [[Triparanol]]<sup>‡</sup> | ||
+ | * [[Volanesorsen]] | ||
− | + | | list6 = {{PharmNavFootnote}} | |
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
}}<noinclude> | }}<noinclude> | ||
− | + | {{collapsible option}} | |
− | + | [[Category:Drug templates by ATC]] | |
− | [[ | ||
</noinclude> | </noinclude> |
Latest revision as of 14:49, 3 January 2021
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Lipid modifying agents|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Lipid modifying agents|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Lipid modifying agents|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.